TIFFANY HALE: Open Payments
NPI 1225498819 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 15 payments from 8 companies in 2025. Trend: 2023 $186 · 2024 $329 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $82 |
| Genentech USA, Inc. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| ABBVIE INC. | 2 | $36 |
| ARRAY BIOPHARMA INC | 1 | $29 |
| Incyte Corporation | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: TECVAYLI, PLUVICTO, Polivy, XALKORI, IMFINZI, Tecentriq, LYNPARZA, JAKAFI.
Industry payments across TX — which companies pay providers there.
